Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Advances in Pharmacological and Pharmaceutical Sciences is Scopus-indexed (Q1, CiteScore 5.6), WoS ESCI, DOAJ. Published by John Wiley and Sons Ltd.
Checked against the index lists dated .
ISSN 2633-4682Verify ISSN ↗2633-4690Verify ISSN ↗
Publisher: John Wiley and Sons Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (all) | 14 / 79 | 82nd | Q1 |
| Pharmacology (medical) | 77 / 278 | 72nd | Q2 |
| Organic Chemistry | 75 / 215 | 65th | Q2 |
| Biochemistry | 193 / 448 | 56th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2020–present, best quartile Q1, CiteScore 5.6.
Advances in Pharmacological and Pharmaceutical Sciences is Q1 in Pharmacology, Toxicology and Pharmaceutics (all) (rank 14 of 79), Q2 in Pharmacology (medical) (rank 77 of 278) and Q2 in Organic Chemistry (rank 75 of 215), by CiteScore 2025. It is ranked in 4 subject areas in all.
Advances in Pharmacological and Pharmaceutical Sciences is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.6, which places it in quartile Q1 at the 82nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.658, quartile Q1, with an H-index of 55.
The publisher lists an article processing charge of about US$1,000 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Advances in Pharmacological and Pharmaceutical Sciences is published by John Wiley and Sons Ltd. Its print ISSN is 2633-4682 and its online ISSN is 2633-4690.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Advances in Pharmacological and Pharmaceutical Sciences has an h-index of 26 and a 2-year mean of 3.37 citations per paper (OpenAlex). Its Scopus CiteScore is 5.6, quartile Q1. On 2-year citations it ranks #18 of 77 Scopus journals in Pharmacology, Toxicology and Pharmaceutics (all).
Advances in Pharmacological and Pharmaceutical Sciences published 50 papers in 2025; its busiest recent year was 2024 with 87. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2024–2026), authors are most often from Thailand (18.5%), India (6.8%) and Indonesia (6.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (5.8 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.